Welcome to our dedicated page for Crh Plc SEC filings (Ticker: CRH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking CRH’s margins across aggregates, cement, and asphalt shouldn’t mean wading through hundreds of technical pages. Each CRH plc filing blends commodity price movements, infrastructure demand metrics, and quarry reserve data—information investors need, but rarely have time to decode.
Stock Titan solves that problem. Our AI reads every document the moment it hits EDGAR and delivers clear explanations your spreadsheet can use. Whether it’s a CRH quarterly earnings report 10-Q filing that details regional volume shifts, or an unexpected CRH 8-K material events explained alert about an acquisition, you receive concise summaries, key numbers, and contextual commentary in real time.
Looking for ownership moves? We stream CRH Form 4 insider transactions real-time so you can spot executive stock purchases before the market reacts. Need the big picture? The CRH annual report 10-K simplified section outlines plant capacity, raw-material reserves, and segment profitability—no legalese required. You’ll also find:
- CRH insider trading Form 4 transactions with filters for executive roles
- CRH proxy statement executive compensation breakdowns to assess incentive structures
- CRH earnings report filing analysis comparing quarter-over-quarter pricing trends
From understanding CRH SEC documents with AI to monitoring CRH executive stock transactions Form 4, every disclosure is organised, searchable, and paired with expert commentary. Complex building-materials filings, explained simply—so you can focus on decisions, not document hunting.
GeneDx Holdings (WGS) 10-Q � quarter ended 30 Jun 2025. Revenue jumped 46 % YoY to $102.7 m, driven by third-party insured diagnostic testing (79 % of sales). Gross profit rose 65 % to $70.9 m (gross margin 69 % vs 61 %). Expense discipline and higher scale flipped operating results to a $9.0 m profit versus a $10.6 m loss last year; net income reached $10.8 m (diluted EPS $0.36) versus a $29.2 m loss (-$1.10 EPS).
Six-month view: revenue +43 % to $189.8 m and net income $4.3 m versus a $49.4 m loss. Operating cash flow turned positive at $20.6 m; however, M&A and cap-ex drove $45.8 m of investing outflow, cutting cash & equivalents to $74.1 m (total liquidity incl. securities $134.6 m).
Balance sheet: total assets $463.9 m. Stockholders� equity improved to $277.1 m. Debt remains $55.1 m (Perceptive Term Loan $50 m due 2028, 7.5 %+SOFR). Goodwill/intangibles increased $34.0 m after the $36.9 m Fabric Genomics acquisition; contingent earn-out valued at $4.3 m.
Key risks: payor concentration (top two groups = 57 % of Q2 revenue, 41 % of receivables), supplier reliance, rising third-party payor reserves ($17.6 m), and high warrant exercise price ($379.50).
Outlook: Management continues to exit non-core reproductive/tumor testing and integrate Fabric’s AI interpretation platform, targeting margin expansion and cash breakeven. Liquidity appears adequate for near-term operations, but execution on revenue milestones and debt servicing will be closely watched.
CRH plc filed a routine Form SD for the fiscal year ended 31 December 2024. The filing confirms that no conflict-minerals disclosure is required under Item 1.01 and instead focuses on resource-extraction payments pursuant to Rule 13q-1. To satisfy U.S. requirements, the company is relying on its EU- and UK-mandated “Report on Payments to Governments for Extractive Activities,� which is posted on CRH’s website and submitted to the UK FCA’s National Storage Mechanism. The report is also furnished as Exhibit 2.01. Signed by CFO Nancy Buese on 26 June 2025, the filing signals ordinary compliance and provides no new financial or strategic information likely to impact valuation.
FAQ
What is the current stock price of Crh Plc (CRH)?
What is the market cap of Crh Plc (CRH)?
What does CRH plc do?
What is CRH’s primary market?
How does CRH generate revenue?
What is CRH’s competitive advantage?
What challenges does CRH face?
What products does CRH offer?
What industries does CRH serve?
How is CRH positioned in the global market?
